HTC
MEDP icon

Haverford Trust Company’s Medpace MEDP Stock Holding History

Haverford Trust Company’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Sell
462
-31
-6% -$14.3K ﹤0.01% 386
2026
Q1 		$237K Buy
+493
New +$252K ﹤0.01% 397

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Haverford Trust Company's MEDP Position: Q2 2026 in Review

Haverford Trust Company reduced its Medpace (MEDP) stake by 6.3% in Q2 2026, selling an estimated $14.3K and leaving 462 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #386.

Haverford Trust Company first reported a position in MEDP in Q1 2026 and has held it in 2 quarters since. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Haverford Trust Company held 462 shares of Medpace worth $245K as of Q2 2026.
  • Haverford Trust Company sold 31 Medpace shares in Q2 2026, an estimated $14.3K.
  • Medpace made up ﹤0.01% of Haverford Trust Company's portfolio in Q2 2026, its #386 holding.
  • Haverford Trust Company first reported a position in Medpace in Q1 2026 and has held it in 2 quarters since.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Haverford Trust Company's 13F filing for Q2 2026, filed 12 Aug 2026.